Aura Biosciences, Inc.AURANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-81.06M
↓ 71% below average
Average (5y)
$-47.30M
Historical baseline
Range
High:$-22.89M
Low:$-81.06M
CAGR
+28.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-81.06M | -25.6% |
| 2023 | $-64.56M | -15.9% |
| 2022 | $-55.70M | -61.3% |
| 2021 | $-34.53M | -37.6% |
| 2020 | $-25.09M | -9.6% |
| 2019 | $-22.89M | - |